Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsgenetics-dysmorphology-and-metabolism

Paeds SAQs · genetics-dysmorphology-and-metabolism

Fragile X syndrome — formative SAQs

Formative SAQs on recognising fragile X syndrome, confirming the molecular diagnosis with FMR1 PCR plus methylation analysis, classifying the CGG-repeat allele, building comorbidity-driven multidisciplinary support, and running cascade testing of the wider family.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Fragile X syndrome

SAQ 1 (10 marks)

A three-year-old boy is referred for global developmental delay and "autistic features". He walked at 20 months and has fewer than ten single words. His mother's brother has intellectual disability and lives in supported accommodation. A previous paediatrician sent a chromosomal microarray, which returned normal. The parents ask why you are ordering more tests. [1] [5]

a) Explain why a normal chromosomal microarray does not exclude fragile X syndrome, and name the specific two-part molecular test you will order. (3 marks) [1] [5]

b) Define the four FMR1 CGG-repeat allele classes, giving the repeat boundaries and methylation status of each. (3 marks) [3] [5]

c) Outline the comorbidity-driven management plan for this child, naming four domains beyond the genetic result that require active surveillance and support. (2 marks) [1]

d) Describe the cascade-testing obligation to the wider family, including the premutation-associated conditions you would screen for in his mother. (2 marks) [1] [9]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Hersh JH, Saul RA Health supervision for children with fragile X syndrome. Pediatrics, 2011.PMID 21518720
  2. [3]Santoro MR, Bray SM, Warren ST. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol, 2012.PMID 22017584
  3. [5]Pirozzi F, Tabolacci E, Neri G. The FRAXopathies: definition, overview, and update. Am J Med Genet A, 2011.PMID 21739597
  4. [9]Hagerman R, et al. Insight and recommendations for fragile X-premutation-associated conditions from the Fifth International Conference. Cells, 2023.PMID 37759552
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousFatty-acid oxidation disorders — formative SAQsgenetics-dysmorphology-and-metabolismNextGenetic deafness and blindness syndromes — formative SAQsgenetics-dysmorphology-and-metabolism